沉默STUB1通过诱导NRF2-介导的M2巨细胞极化来缓解骨关节炎
Nan Cao1, Danni Wang1, Bin Liu1
1Department of Orthopedics, General Hospital of Northern Theater Command, Shenyang 110016, Liaoning Province, China.
Molecular immunology
|November 22, 2023
概括
沉默STUB1将巨细胞转移到抗炎M2状态,通过抑制NRF2无处不在,缓解骨关节炎的进展和损伤. 这一发现为骨关节炎治疗提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 骨关节炎 (OA) 的发病包括由亲炎性M1巨细胞驱动的慢性炎症.
- 将巨细胞转移到抗炎M2表型是OA的一种有前途的治疗策略.
- 在OA中调节巨细胞极化的精确分子机制尚未完全理解.
研究的目的:
- 在OA的背景下,研究STUB1 (一种E3泛基因酶) 在巨细胞极化中的作用.
- 阐明STUB1影响OA病理的潜在分子机制.
主要方法:
- 建立了OA的体内大鼠模型和体内脂聚糖 (LPS) 诱导的淋巴细胞模型.
- 评估了组织病理学变化,巨细胞两极分化 (M1/M2) 和炎症标志物 (TNF-α,IL-6).
- 利用共同免疫沉 (CO-IP) 和拉下测试来确定STUB1-NRF2相互作用和无处不在.
主要成果:
- 沉默STUB1显著缓解了老鼠的OA症状,减少了炎症和组织损伤.
- STUB1 knockdown促进了M2巨细胞的两极分化,并在体内和体外抑制了M1巨细胞.
- STUB1直接无处不在NRF2,NRF2对于STUB1对M2极化的影响至关重要. 沉默STUB1提高了NRF2的调节,增强了状细胞的活力,减少了亡.
结论:
- 抑制STUB1通过抑制NRF2的无化促进了M2巨细胞的两极分化,从而减轻了OA.
- 向STUB1代表了通过调节巨细胞表型来管理骨关节炎的潜在治疗方法.
更多相关视频
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
19.7K
09:18Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
7.6K
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
